Sign Up

Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships
Flyout Menu
Main Menu

Media

Press and media

EASL collaborates with a range of trusted media partners to amplify the reach of liver science and share the latest developments in hepatology with a wider audience. Through these partnerships, we promote EASL events, publications and initiatives, while supporting accurate, high-quality coverage of advances in liver research and care. If you are a media outlet interested in covering EASL activities or becoming a media partner, we invite you to get in touch with us.

Media

Our media partners

Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website

Press Releases

  • EASL News, Press Release

EASL journal JHEP Reports to receive its first impact factor in 2022

25 January 2022 It is with great pleasure that EASL announces that their first open-access journal JHEP Reports has been accepted into Clarivate’s Science Citation…
Read More
  • EASL News, Press Release

New study shows link between long-term exposure to air pollution and liver disease

A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and metabolic-associated fatty liver disease (MAFLD), report scientists in…
Read More
  • EASL News, Press Release

The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe

The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe: prevention and early detection, not end-stage treatment of complications….
Read More
  • EASL News, Press Release

Journal of Hepatology ranking soars, remaining the leader among specialist hepatology journals

ClarivateTM Analytics released the 2021 update of its Journal Citation Reports©, including the much anticipated 2020 impact factor. EASL’s flagship monthly journal, the Journal of…
Read More
  • Press Release

Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021

For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 New data released on trials involving RNAi therapeutics,…
Read More
  • Press Release

Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021

For Immediate Release Media Release Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021 Thursday 24 June 2021…
Read More
  • Press Release

ILC 2021 opens with focus on impact of COVID-19 on global liver disease

For Immediate Release Media Release ILC 2021 opens with focus on impact of COVID-19 on global liver disease New data demonstrates that chronic liver disease…
Read More
  • EASL News, Press Release

A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope

About EASL and the A-TANGO Consortium The A-TANGO Consortium, a five-year project, consists of 14 institutions across eight countries in Europe. It aims to perform…
Read More
  • EASL News, Press Release

On Rare Disease Day, we honour the many, the strong, the proud

EASL honours Rare Disease Day, taking place this Sunday, 28 February. An estimated 300 million people globally are affected by rare diseases – diseases of…
Read More
  • EASL News, Press Release

EASL policy statement on the use of COVID-19 vaccines in people with chronic liver disease, hepatobiliary cancer, and liver transplant recipients

9 February 2021 By end-January 2021, COVID-19, the systemic disease caused by the pandemic spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), accounted for…
Read More
Scroll to Top

Search EASL